Clinical trial

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or…

NCT00161187 · University of Medicine and Dentistry of New Jersey, Other · Completed

Key facts

NCT number NCT00161187
Title Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Official title A Pilot Study of Irradiated HLA-Partially Matched Allogeneic Related Donor Lymphocytes for Patients With Selected Malignancies
Lead sponsor University of Medicine and Dentistry of New Jersey, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Cancer
Intervention type Biological
Interventions therapeutic allogeneic lymphocytes
Enrollment 37
Start date May 1, 2001
Primary completion Oct 1, 2010
Completion Oct 1, 2011
First posted Sep 12, 2005
Last update posted Nov 6, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies